Jeffrey H Silber1. Show Affiliations » 1. Center for Outcomes Research, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. silber@email.CHOP.edu
Abstract
Entities: Chemical Disease Species
Mesh： See more » Antibiotics, Antineoplastic/adverse effectsCardiomyopathies/bloodCardiomyopathies/chemically inducedCardiomyopathies/prevention & controlCardiovascular Agents/therapeutic useChelating Agents/therapeutic useChildClinical Trials as TopicDisease-Free SurvivalDoxorubicin/adverse effectsHumansPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrognosisRazoxane/therapeutic useTroponin T/blood
Substances： See more » Antibiotics, AntineoplasticCardiovascular AgentsChelating AgentsTroponin TRazoxaneDoxorubicin
Year: 2004 PMID： 16264791 DOI： 10.1038/ncponc0023
Source DB: PubMed Journal: Nat Clin Pract Oncol ISSN： 1743-4254